Since 1935 committed to improving patients quality of vision. SIFI is expanding into international markets providing innovative solutions for ocular diseases.
We are delighted to share with you our important regulatory progress in EU and the US for the treatment of the acute and devastating disease of acanthamoeba keratitis.
Read the follow article for more details:
https://t.co/cdIMfV1OaW
#acanthamoebakeratitis#ophthalmology
Happy to announce Phase III study on polihexanide 0,08% monotherapy in adults and adolescents with Acanthamoeba keratitis (AK), met its primary endpoint of ‘clinical resolution rate over a 12-month timeframe’.
To read the full article:
https://t.co/8TSczaTlZO
Siamo lieti di comunicare che AIFA, ha autorizzato la modifica della posologia di NETILDEX® gel oftalmico con riduzione del numero di somministrazioni giornaliere da 4 a 2.
📌Per saperne di più:
https://t.co/wmRPUDDRfd
#innovation#ophthalmology#cataractsurgery
Sicily-based ophthalmic product specialist SIFI Group has grown since its establishment in 1935.
Last year, they launched Well Fusion, a novel formulation of artificial tears.
To find out below about their innovations, read our itw with Fabrizio Chines.
https://t.co/gQ7SLwCyhX
Sicily-based ophthalmic product specialist SIFI Group has grown since its establishment in 1935.
Last year, they launched Well Fusion, a novel formulation of artificial tears.
To find out below about their innovations, read our itw with Fabrizio Chines.
https://t.co/gQ7SLwCyhX
BIO Digital 2021 @IAmBiotech will be an opportunity to present some of SIFI’s most significant #research projects with a view to identify strategic partners for some of its late-stage assets and patented drug-delivery platforms. https://t.co/HIcjtrpk6i #innovation#biotech
On @EyewireNews Gilberto Dalesio SIFI’s CCO "SIFI is committed to continuous development and expansion and is pleased to announce this strategic partnership with Bausch Health Russia." https://t.co/1vST7MV0kO #pharma#ophthalmology#health#industrynews#Pharmaceuticals#Russia
Hoy a las 18:00 h. en el 36 Congreso #SECOIR2021 el simposio de @sifigroup con los expertos Dr. Güell, Prof. Auffarth y Dr. Ruiz Mesa que nos presentarán un innovador sistema de lentes de visión ininterrumpida. Más información e inscripciones en 👁️🗨️ https://t.co/bxwQTDEcim
SIFI e Bausch Health Russia annunciano una partnership commerciale strategica in Russia che garantirà un maggiore accesso a importanti farmaci per la cura degli occhi: https://t.co/y9hI99fcLK #occhi#salute#oftalmologia#farmaceutica
SIFI Initiates Patient Enrollment in Phase II Trial evaluating Pro-ocular in Dry Eye Disease. Trial involves 4 leading ophthalmic centers in Italy & is expected to recruit 105 participants: https://t.co/0jmTmOcGg1 #dryeye#innovation#research#biotech#pharma#Ophthalmology